Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
马鹿胎益母草胶囊 (Red Deer Placenta and Motherwort Capsule) is an oral health supplement developed and manufactured by Jilin Fukang Pharmaceutical. The formulation combines red deer placenta (Cervus elaphus) with motherwort (Leonurus japonicus), two ingredients traditionally used in Chinese medicine for women's health. Red deer placenta is believed to tonify the kidneys and nourish blood and essence, while motherwort is recognized for its ability to promote blood circulation and regulate the menstrual cycle. The product is primarily indicated for the relief of menstrual irregularities and to support recovery following childbirth. It is categorized as a health supplement (nutraceutical) in the Chinese market, often identified by the 'Blue Hat' registration for health foods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 马鹿胎益母草胶囊.